Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chlebowski

Showing results (81-90 of 379) with videos related to

Pageof 38
Sort By:
Annals of Surgical Oncology|July 30, 2020
Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and SurvivalChristine Dauphine, Ashkan Moazzez, Jasmin C Neal, et al.
Oncology|January 1, 1988
Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group TrialR T Chlebowski, S Nystrom, R Reynolds, et al.
American Journal of Clinical Dermatology|January 20, 2023
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women's Health InitiativeWendy Li, Alfred A Chan, Jiali Han, et al.
Cancer Medicine|October 25, 2013
Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005Shagufta Yasmeen, Rowan T Chlebowski, Guibo Xing, et al.
Oncology|January 1, 1985
Cyclophosphamide plus 5-FU versus 5-FU alone in advanced gastric carcinomaR T Chlebowski, J M Weiner, I Silverberg, et al.
Breast Cancer Research and Treatment|August 1, 2012
Metformin and breast cancer risk: a meta-analysis and critical literature reviewNananda F Col, Leslie Ochs, Vicky Springmann, et al.
Breast Cancer Research and Treatment|December 1, 1989
Mitoxantrone use in breast cancer patients with elevated bilirubinR T Chlebowski, L Bulcavage, I C Henderson, et al.
American Journal of Epidemiology|May 17, 2008
Body mass index and waist circumference in relation to lung cancer risk in the Women's Health InitiativeGeoffrey C Kabat, Mimi Kim, Julie R Hunt, et al.
Cancer|August 15, 1983
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trialR T Chlebowski, R Pugh, J M Weiner, et al.
Cancer|May 1, 1980
Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white blood cell countR T Chlebowski, I Silverberg, T Pajak, et al.
Pageof 38

Showing results (81-90 of 379) with videos related to

Sort By:
Pageof 38
Annals of Surgical Oncology|July 30, 2020
Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and SurvivalChristine Dauphine, Ashkan Moazzez, Jasmin C Neal, et al.
Oncology|January 1, 1988
Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group TrialR T Chlebowski, S Nystrom, R Reynolds, et al.
American Journal of Clinical Dermatology|January 20, 2023
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women's Health InitiativeWendy Li, Alfred A Chan, Jiali Han, et al.
Cancer Medicine|October 25, 2013
Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005Shagufta Yasmeen, Rowan T Chlebowski, Guibo Xing, et al.
Oncology|January 1, 1985
Cyclophosphamide plus 5-FU versus 5-FU alone in advanced gastric carcinomaR T Chlebowski, J M Weiner, I Silverberg, et al.
Breast Cancer Research and Treatment|August 1, 2012
Metformin and breast cancer risk: a meta-analysis and critical literature reviewNananda F Col, Leslie Ochs, Vicky Springmann, et al.
Breast Cancer Research and Treatment|December 1, 1989
Mitoxantrone use in breast cancer patients with elevated bilirubinR T Chlebowski, L Bulcavage, I C Henderson, et al.
American Journal of Epidemiology|May 17, 2008
Body mass index and waist circumference in relation to lung cancer risk in the Women's Health InitiativeGeoffrey C Kabat, Mimi Kim, Julie R Hunt, et al.
Cancer|August 15, 1983
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trialR T Chlebowski, R Pugh, J M Weiner, et al.
Cancer|May 1, 1980
Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white blood cell countR T Chlebowski, I Silverberg, T Pajak, et al.
Pageof 38